Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole SodiumCategory 1.1 Ne...

HONG KONG, 17 July 2013 – Sihuan Pharmaceutical Holdings Group Ltd. announced that Anaprazole Sodium, a Category 1.1 new drug received the Approval for Clinical Studies from the State Food and Drug Administration (“SFDA”) of the People’s Republic...

Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole SodiumCategory 1.1 New Drug Clinical Studies
2014-11-11
Sihuan Pharmaceutical Secures IND Number for Self-Developed Innovative Patented Oncology Drug ‘Pirotinib’

Sihuan Pharmaceutical Holdings Group Ltd. has submitted an Investigational New Drug (IND) application for Pirotinib (“Pirotinib” or the “new drug”), a self-developed innovative patented oncology d...

2014-11-05
Congrats to Jilin Sihuan on Winning Jilin Innovation-oriented Science and Technology Enterprise

In November 2014, Jilin Sihuan Pharmaceutical Co., Ltd. (refered to as “Jinlin Sihuan”), a wholly owned subsidiary of Sihuan Pharmceutical Holdings Group Ltd., was honored the award of Jilin Innov...

2014-08-28
Sihuan Pharmaceutical Announces 2014 Interim Results

Sihuan Pharmaceutical Announces 2014 Interim Results, Profit Attributable to Owners of the Company Up by 34.4%

2014-06-30
Congrats to Beijing Sihuan Pharm for Ranking in the Top 100 Chinese Pharmaceutical Companies 2013

The 31st National Pharmaceutical Industry Information Annual Conference 2014, which was convened in Qingdao on June 28, 2014, announced the Top 100 Chinese Pharmaceutical Companies in 2013. Beijing Sihuan Pharmaceutical Co., Ltd., was ranked the 37th among the Top 100.

2014-05-28
Langfang Gaobo Jingband Successfully Passed FDA’s On-site Inspection

Langfang Gaobo Jingband Pharmaceutical has successfully passed the on-site inspection conducted by U.S. Food and Drug Administration (FDA)

Total 7 Pages  First page  Page up  Page down  Last page

Select

  • 2014
  • 2013
  • 2012